A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms
- 15 January 1991
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 9 (3), 261-269
- https://doi.org/10.1016/0731-7085(91)80156-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Impurity profiling of clarithromycin using high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography A, 1990
- Replacement of microbiological assays of antibiotics based on high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1989
- Chromatographic methods for determining the identity, strength and purity of ranitidine hydrochloride both in the drug substance and its dosage from—an exercise in method selection, development, definition and validationJournal of Pharmaceutical and Biomedical Analysis, 1989
- Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Replacement of microbiological assay by high-performance liquid chromatographic assay for antibioticsJournal of Pharmaceutical and Biomedical Analysis, 1987